The Neurointervention Center

Filter Your Results




Carotid Occlusion With Middle Cerebral Artery Thrombus

Moderators: Adnan H. Siddiqui, MD, PhD; and Kunal Vakharia, MD;
Panel: Ansaar T. Rai, MD, MBA; and Aquilla S. Turk, DO

August 2018—CASE PRESENTATION A 54-year-old woman with a history of hypertension presented with left upper extremity weakness and facial droop with a National Institutes of Health Stro…

iSchemaView’s Rapid Platform Approved in Canada

August 16, 2018 -- iSchemaView announced it has received final approval in Canada for the use of the Rapid cerebrovascular imaging analysis platform. The Rapid platform is des…

CE Mark Approval Granted for Cerenovus' Bravo Flow Diverter to Treat Intracranial Aneurysms

August 8, 2018 -- Cerenovus, part of the Johnson & Johnson Medical Devices Companies, announced it has received European CE Mark approval for the Bravo flow diverter for u…

Athersys' MultiStem Cell Therapy for Ischemic Stroke to Be Studied in MASTERS-2

July 31, 2018 -- Athersys, Inc. announced that the first patient has been enrolled in its phase 3 MASTERS-2 study evaluating the administration of the company's MultiStem …

Rapid Medical's Intracranial Tigertriever 13 Receives CE Mark Approval

July 31, 2018 -- Rapid Medical announced that it has received European CE Mark approval for the Tigertriever 13, the next-generation in the company's Tigertriever family o…

Real-World Data Support Longer Time Window for Stent Retriever Thrombectomy After Stroke

July 26, 2018 -- The Society of NeuroInterventional Surgery (SNIS) announced that a new study shows promising real-world outcomes for patients treated by stent retriever throm…

Delays to Thrombectomy for Stroke Shown to Reduce Quality-of-Life and Economic Outcomes

July 24, 2018 -- The Society of NeuroInterventional Surgery (SNIS) announced findings from a study using a Markov model of lifetime quality-adjusted life years (QALYs) in pati…

Cerenovus Launches Next-Generation Embotrap II Stent Retriever

July 24, 2018 -- Cerenovus, part of the Johnson & Johnson Medical Devices Companies, announced the launch of its Embotrap II revascularization device at the Society of Neu…



2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.